Stereotactic body radiation therapy (SBRT) for oligometastatic soft tissue sarcoma (STS)

被引:0
|
作者
Botticella, A. [1 ]
Jornet, D. [1 ]
Tang, E. [1 ]
Henry, O. [1 ]
Auzac, G. [1 ]
Chabert, I. [1 ]
Dumond, S. [2 ]
Mir, O. [2 ]
Haddag-Miliani, L. [3 ]
Mihoubi, F. [3 ]
Le Cesne, A. [2 ]
Faron, M. [4 ]
Cavalcanti, A. [4 ]
Terrier, P. [5 ]
Adam, J. [5 ]
Honore, C. [4 ]
Levy, A. [1 ]
Le Pechoux, C. [1 ]
机构
[1] Gustave Roussy, Dept Radiat Oncol, Villejuif, France
[2] Gustave Roussy, Dept Oncol, Villejuif, France
[3] Gustave Roussy, Dept Radiol, Villejuif, France
[4] Gustave Roussy, Dept Surg Oncol, Villejuif, France
[5] Gustave Roussy, Dept Pathol, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0457
引用
收藏
页码:S254 / S254
页数:1
相关论文
共 50 条
  • [21] Outcomes from Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Colorectal Cancer (CRC)
    Dayal, A.
    Rosser, C.
    Deng, M.
    Ruth, K.
    Denlinger, C.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E564 - E565
  • [22] Stereotactic body radiation therapy (SBRT)
    Heijmen, B.
    Romero, A. Mendez
    Wunderink, W.
    de Pooter, J.
    Hoogeman, M.
    Nuyttens, J.
    Levendag, P.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S21 - S21
  • [23] Stereotactic body radiation therapy (SBRT) for liver metastases in oligometastatic patients treated with the CyberKnife® system
    Semrau, R.
    Kocher, M.
    Temming, S.
    Baues, C.
    Brendemuehl, A.
    Baus, W.
    Marnitz-Schulze, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 97 - 97
  • [24] Stereotactic Ablative Radiotherapy for oligometastatic soft tissue sarcoma patients
    Greto, D.
    Loi, M.
    Pezzulla, D.
    Lo Russo, M.
    Teriaca, M. A.
    Maragna, V.
    Lucidi, S.
    Campanacci, D. A.
    Beltrami, G.
    Scoccianti, G.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S866 - S866
  • [25] Stereotactic Body Radiation Therapy (SBRT) and Image Guided Accelerated Hypofractionated Radiation Therapy (IGAHRT) for the Treatment of Oligometastatic Cancers
    Ayala-Peacock, D. N.
    Blackstock, A. W.
    Kearns, W. T.
    Hinson, W. H.
    Munley, M. T.
    Miller, A. A.
    Petty, W. J.
    Urbanic, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S567 - S568
  • [26] Non-surgical Treatments for Lung Metastases in Patients with Soft Tissue Sarcoma: Stereotactic Body Radiation Therapy (SBRT) and Radiofrequency Ablation (RFA)
    Tetta, Cecilia
    Carpenzano, Maria
    Algargoush, Areej T. J.
    Algargoosh, Marwah
    Londero, Francesco
    Maessen, Jos G.
    Gelsomino, Sandro
    CURRENT MEDICAL IMAGING, 2021, 17 (02) : 261 - 275
  • [27] Outcomes and Prognostic Factors of Stereotactic Body Radiation Therapy for Soft-Tissue Sarcoma Metastases
    Merrell, K. W.
    Francis, S. R.
    Mou, B.
    Hallemeier, C. L.
    Olivier, K. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S765 - S766
  • [28] Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
    Nikitas, John
    Roach, Michael
    Robinson, Cliff
    Bradley, Jeffrey
    Huang, Jiayi
    Perkins, Stephanie
    Tsien, Christina
    Abraham, Christopher
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 21 : 32 - 35
  • [29] Is There a Role for Stereotactic Body Radiation Therapy (SBRT) in Oligometastatic Breast Cancer? Results From an Observational Study
    De Rose, F.
    Franceschini, D.
    Cozzi, L.
    Comito, T.
    D'Agostino, G. R.
    Navarria, P.
    Ascolese, A. M.
    Tozzi, A.
    Iftode, C.
    Franzese, C.
    Clerici, E.
    Tomatis, S.
    Fogliata, A.
    Scorsetti, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E12 - E12
  • [30] Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer
    Martinez-Fernandez, M. I.
    Perez Gracia, J. L.
    Gil-Bazo, I.
    Martinez-Monge, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 743 - 747